웹We evaluated and antitumor activity and secure of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal colorectal (GC/GEJC) previously treated with chemotherapy. In a phase 1b expansion cohort, patients without (1 L-mn) or with (2 L) … 웹Autor: Doc. MUDr. Milada Zemanová, Ph. D.Onkologická klinika, 1. lékařská fakulta University Karlovy v Praze a Všeobecná fakultní nemocnice v Praze V posledních dvaceti letech dochází v západním světě k významným změnám v epidemiologii karcinomů jícnu a žaludku. Zatímco incidence karcinomů těla a výtokové části žaludku významně klesá, dochází k až ...
Neue medikamentöse Therapieansätze des Magenkarzinoms
웹2024년 3월 22일 · Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379:315. Zhang XL, Shi HJ, Cui SZ, et al. Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative … 웹1995년 9월 18일 · Ahn SH, Lee J, Kim YJ, et al. Isolated MCA disease in patients without significant atherosclerotic risk factors: ... Bang OY, Ryoo S, Kim SJ, et al. Adult moyamoya disease: a burden of intracranial stenosis in east Asians? ... a multicentre, observational, cohort study. Lancet Neurol 2009;8(12):1120-7. PMID 19801204. 36 target rubik\u0027s cube 3x3
A metastatic ureteral tumor successfully treated with …
웹41. Bang YJ, Kim YW, Yang HK, et al; CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315-321. 42. Noh SH, Park SR, Yang HK, et al; CLASSIC trial investigators. 웹2016년 10월 4일 · Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012; 379:315 ... European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol. 2010; 28:5210–5218. 17 ... 웹21. Bang YJ, Kim YW, Yang HK. et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315-321 22. Eisenhauer EA, Therasse P, Bogaerts J. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). target sum coding ninjas